(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Mark Long Here's what's making health news this morning: Glaxo Bids for Human Genome Sciences (WSJ): The U.K. company's longtime research partner rejected the $2.6 billion offer, a wager by Glaxo on the prospects of drugs discovered using Human Genome Sciences technology. Veterans Department to Increase Mental Health Staffing (New York Times): In a move to cut lengthy wait times, the VA plans to hire about 1,600 more psychiatrists, psychologists and other mental-health workers. You're Never Too Old to Reduce Alzheimer's Risk With Exercise (Los Angeles Times): A study published in Neurology of 716 people -- mostly women, average age of 81 -- found the 10% who exercised least were 2.3 times more likely to get the disease compared with the 10% who exercised the most. U.S. Officials Seize Contaminated Ultrasound Gel (Reuters): The FDA said samples of "Other-Sonic Generic Ultrasound Transmission Gel," made by a private Newark, N.J., company, posed health risks. Combination of Gilead, Bristol Myers Hepatitis C Drugs Show Promise in Study (WSJ): The results suggest the combo has potential as an all-oral treatment that could eliminate the need for a injected drug used in the standard treatment that some patients find hard to tolerate. -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.
